Nexalin Technology, Inc. Common Stock
Symbol: NXL (NASDAQ)
0.89
▲ (2.48%) 0.022
Company Description:
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
Key Stats
- Today's Open: $0.889
- Today's High: $0.889
- Today's Low: $0.889
- Today's Volume: 275
- Yesterday Close: $0.8675
- Yesterday High: $0.8906
- Yesterday Low: $0.79
- Yesterday Volume: 244.97K
- Last Min Volume: 199
- Last Min High: $0.889
- Last Min Low: $0.889
- Last Min VWAP: $0.889
Company Profile
- Name: Nexalin Technology, Inc. Common Stock
- Website: https://www.nexalin.com
- Listed Date: 2022-09-16
- Location: HOUSTON, TX
- Market Status: Active
- CIK Number: 0001527352
- SIC Code: 3845
- SIC description: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
- Market Cap: $14.13M
- Round Lot: 100
- Outstanding Shares: 17.42M
- Asset Type: CS
RECENT FILINGS FOR NXL
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-10 | 144 | View |
| 2025-08-07 | 3 | View |
| 2025-08-06 | 10-Q | View |
| 2025-08-04 | 8-K | View |
| 2025-07-21 | 8-K | View |
| 2025-07-21 | 4 | View |
| 2025-07-17 | 8-K | View |
| 2025-06-17 | DEF 14A | View |
| 2025-06-09 | 8-K | View |
| 2025-05-13 | 10-Q | View |
| 2025-05-06 | 8-K | View |
| 2025-05-06 | 424B4 | View |
| 2025-05-05 | 424B5 | View |
| 2025-05-05 | 8-K | View |
| 2025-05-02 | 424B4 | View |
| 2025-04-29 | EFFECT | View |
| 2025-04-28 | CORRESP | View |
| 2025-04-23 | S-3 | View |
| 2025-04-17 | 8-K | View |
| 2025-04-15 | 10-K/A | View |
Latest News on NXL